3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
4
Phase NA
2
Phase 3
1
Phase 1/2
1
Status
Recruiting
7
Completed
5
Active not recruiting
3
Withdrawn
2
Unknown
2
Enrolling by invitation
2
Terminated
1
Sponsor
Interventions
fludarabine
5
Cyclophosphamide
5
Surgical Procedures, Operative
2
Standard of Care
2
Immune Checkpoint Inhibitors
2
Bevacizumab
2
venetoclax
1
tucatinib
1
trifluridine tipiracil drug combination
1
tremelimumab
1
trastuzumab deruxtecan
1
tislelizumab
1
tipiracil
1
spartalizumab
1
sotorasib
1
semaglutide
1
selpercatinib
1
posaconazole
1
pembrolizumab
1
peginterferon alfa-2b
1
osimertinib
1
montelukast
1
malic acid
1
icotinib
1
gallium maltolate
1
encorafenib
1
eliglustat
1
durvalumab
1
daratumumab
1
cannabigerol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Not yet recruiting
×
Fluorodeoxyglucose F18
×
Clear all
No trials found.